Skip to content

ReSkin

Active
Private limited companyfounded 20233 yrs activeBistierland 41, 8530 Harelbeke, BelgiumKBO/BCE: BE 0802.150.408

ReSkin has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €170k and a net result of €82k. Equity is growing by ~93.1% per year across the filed fiscal years. Its solvency ranks better than 95% of 16377 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
93 / 100
Excellent▼ -7 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Stability94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €16k at 30 days acceptable
Liquidity ample (current ratio 41.88 against 4.43 in 2024), and 2.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 3 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
97.7%
Return on assets
46.9%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
1 d early
2024
5 d late
2023
8 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
12-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€170k▲ 92.6%
2024 · €88k
2023: €6k 2024: €88k
2023 → 2025
Total assets
€175k▲ 54.6%
2024 · €113k
2023: €29k 2024: €113k
2023 → 2025
Net result
€82k▼ 1.1%
2024 · €83k
2023: €4k 2024: €83k
2023 → 2025
Working capital
€167k▲ 100%
2024 · €84k
2023: €3k 2024: €84k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202320242025Trend
Equity€6k-€88k▲ 1,474%€170k▲ 92.6%
Operating result€7k-€109k▲ 1,572%€104k▼ 4.6%
Net result€4k-€83k▲ 2,187%€82k▼ 1.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100kOperating result 2023: €7k€7kNet result 2023: €4k€4kOperating result 2024: €109k€109kNet result 2024: €83k€83kOperating result 2025: €104k€104kNet result 2025: €82k€82k202320242025
The operating result falls in 2025; 2025 is 5% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €175k
Fixed assets €3k▼ 38.1%
Current assets €172k▲ 58.8%
Equity and liabilities €175k
Equity €170k▲ 92.6%
Debt €4k▼ 83.2%
The debt ratio falls from 21.6% to 2.3%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€106k
2024 · €110k
Cash flow
€84k
2024 · €84k
Solvency
97.7%
2024 · 78.4%
Current ratio
41.88
2024 · 4.43
Quick ratio
41.88
2024 · 4.43
Debt / equity
0.02
2024 · 0.28
ROE
48.1%
2024 · 93.6%
ROA
46.9%
2024 · 73.4%
Interest coverage
35.70
2024 · 33.48
Debt
€4k
2024 · €24k
Debt ≤ 1 year
€4k
2024 · €24k
Income taxes
€22k
2024 · €23k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€113k€175k
Fixed assets21/28€5k€3k
Tangible fixed assets22/27€5k€3k
Plant, machinery and equipment23€3k€2k
Furniture and vehicles24€2k€1k
Current assets29/58€108k€172k
Amounts receivable within one year40/41-€2k
Trade receivables40-€946
Other amounts receivable41-€1k
Current investments50/53-€75k
Cash at bank and in hand54/58€107k€80k
Deferred charges and accrued income490/1€1k€14k
Equity and liabilities
Total equity and liabilities10/49€113k€175k
Equity10/15€88k€170k
Contributions10/11€2k€2k=
Reserves13€86k€168k
Distributable reserves133€86k€168k
Amounts payable17/49€24k€4k
Amounts payable within one year42/48€24k€4k
Trade debts44€6k-
Suppliers440/4€6k-
Taxes, remuneration and social security45€18k€3k
Taxes450/3€18k€3k
Other amounts payable47/48€116€2k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€2k
Other operating charges640/8€3k€3k
Gross operating margin9900€114k€109k
Operating profit (loss)9901€109k€104k
Financial income75/76B€48€3k
Recurring financial income75€48€3k
Financial charges65/66B€3k€3k
Recurring financial charges65€3k€3k
Profit (loss) for the period before taxes9903€106k€104k
Income taxes67/77€23k€22k
Profit (loss) for the period9904€83k€82k
Profit (loss) for the period to be appropriated9905€83k€82k
Appropriation of the result
Profit (loss) to be appropriated9906€83k€82k
Transfer to equity691/2€83k€82k
To other reserves6921€83k€82k

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Liquidity times 9current ratio 41.88
Current ratio from 4.43 to 41.88; short-term debt falls from €24k to €4k.
31-12
Financial Equity above €150kEq €170k ▲92.6%
3 profitable years in a row build equity to €170k.
05-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 5 days late
2024
31-12
Financial Highest result since 2023net €83k ▲2187%
Operating result €109k, net result €83k, both a record.
31-12
Financial Liquidity quadruplescurrent ratio 4.43
Current ratio from 1.11 to 4.43.
23-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Harelbeke · 1 establishment unit since 2023
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Bistierland 418530 Harelbeke
Ground area
2,367 m²
Building footprint
656 m²
2 parcels, Flanders · tallest building 0.1 m. Linked by address, not a title deed.
1 establishment unit
ReSkin
Groenestraat 315, 8800 RoeselareSpecialist medical practice
since 20232.345.735.657
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
36503C1239/00P003 Flanders 2,166 m² 1 · 574 m² 0.1 m
34323D1456/00T002 Flanders 202 m² 1 · 81 m² -
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,599 companies in sector 86220 we hold annual accounts for 7,959. 6,793 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded26-05-2023
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 11-09-2026. Scores and ratios are computed by Checked and are not a credit decision.